KVV04601
HSV-1/HHV-1 gG/US4
Colorimetric
Plasma, Serum
Quantitative
1.56 - 100 ng/mL
0.65 ng/mL
CV<15%
80-120%
2-8 ℃
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
For research use only.
Natural zoonotic infections of two marmosets and one domestic rabbit with herpes simplex virus type 1 did not reveal a correlation with a certain gG-, gI- or gE genotype., PMID:20121821
The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies., PMID:20171247
Application and expression of HSV gG1 protein from a recombinant strain., PMID:20705103
Prevalence and risk factors for herpes simplex infection among patients at high risk for HIV infection in Brazil., PMID:21595666
Characterization of herpes simplex virus clinical isolate Y3369 as a glycoprotein G variant and its bearing on virus typing., PMID:21658271
Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006., PMID:22085620
Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling., PMID:22318154
Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses., PMID:22319442
Prevalence of herpes simplex virus type 1 glycoprotein G (gG) and gI genotypes in patients with different herpetic diseases during the last four decades., PMID:22337305
Phylogenetic comparison of exonic US4, US7 and UL44 regions of clinical herpes simplex virus type 1 isolates showed lack of association between their anatomic sites of infection and genotypic/sub genotypic classification., PMID:22416856
Characterization of the viral O-glycopeptidome: a novel tool of relevance for vaccine design and serodiagnosis., PMID:22491453
Evaluation of antibodies against glycoprotein D (gD) and glycoprotein G (gG) in HSV-1 infected individuals' serum samples., PMID:22696877
Sequence of a fusogenic herpes simplex virus, RH2, for oncolytic virotherapy., PMID:23239570
A cationic peptide, TAT-Cd°, inhibits herpes simplex virus type 1 ocular infection in vivo., PMID:23341013
Molecular characterization of clinical isolates of herpes simplex virus type 1 collected in a tertiary-care hospital in Dublin, Ireland., PMID:23508909
Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology., PMID:23514126
[Rash and fever illness caused by herpes simplex virus type 1 needs to be distinguished from hand, foot and mouth disease]., PMID:23895007
Contributions of herpes simplex virus 1 envelope proteins to entry by endocytosis., PMID:24109213
IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections., PMID:24496316
Identification of an immunodominant epitope in glycoproteins B and G of herpes simplex viruses (HSVs) using synthetic peptides as antigens in assay of antibodies to HSV in herpes simplex encephalitis patients., PMID:25283862
Development of a time-resolved fluorescence immunoassay for herpes simplex virus type 1 and type 2 IgG antibodies., PMID:25377426
Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential., PMID:25532518
Secreted herpes simplex virus-2 glycoprotein G modifies NGF-TrkA signaling to attract free nerve endings to the site of infection., PMID:25611061
Herpes simplex virus enhances chemokine function through modulation of receptor trafficking and oligomerization., PMID:25625471
Binding of the pathogen receptor HSP90AA1 to avibirnavirus VP2 induces autophagy by inactivating the AKT-MTOR pathway., PMID:25714412
Evaluation of Effect of Topical Tacrolimus Treatment on Herpetic Stromal Keratitis in a Rat Model., PMID:25996419
Genotypic Characterization of Herpes Simplex Virus Type 1 Isolates in Immunocompromised Patients in Rio de Janeiro, Brazil., PMID:26407292
False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands., PMID:26755775
Quantitative Trait Locus Based Virulence Determinant Mapping of the HSV-1 Genome in Murine Ocular Infection: Genes Involved in Viral Regulatory and Innate Immune Networks Contribute to Virulence., PMID:26962864
Mapping Murine Corneal Neovascularization and Weight Loss Virulence Determinants in the Herpes Simplex Virus 1 Genome and the Detection of an Epistatic Interaction between the UL and IRS/US Regions., PMID:27384650
Genotyping of herpes simplex virus type 1 by whole-genome sequencing., PMID:27558891
Herpes simplex virus particles interact with chemokines and enhance cell migration., PMID:27692045
Detection systems for antibody responses against herpes B virus., PMID:32110687
Diagnosis of human herpes virus 1 and 2 (HHV-1 and HHV-2): use of a synthetic standard curve for absolute quantification by real time polymerase chain reaction., PMID:28225902
Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections., PMID:28238255
Comparison of commercial methods of immunoblot, ELISA, and chemiluminescent immunoassay for detecting type-specific herpes simplex viruses-1 and -2 IgG., PMID:28332725
Expression and characterization of the soluble form of recombinant mature HSV-2 glycoprotein G for use in anti-HSV-2 IgG serodiagnostic immunoassay., PMID:29104048
Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population., PMID:30814317
The PILRA G78R Variant Correlates with Higher HSV-1-Specific IgG Titers in Alzheimer's Disease., PMID:31297637
Complement and CD4+ T cells drive context-specific corneal sensory neuropathy., PMID:31414985
Identification of the Cleavage Domain within Glycoprotein G of Herpes Simplex Virus Type 2., PMID:33322659
Antiviral Activity of Zinc Oxide Nanoparticles Mediated by Plumbago indica L. Extract Against Herpes Simplex Virus Type 1 (HSV-1)., PMID:34955639
A Baseline Cellular Antiviral State Is Maintained by cGAS and Its Most Frequent Naturally Occurring Variant rs610913., PMID:35851540
Herpes Simplex Virus 1 Glycoproteins Differentially Regulate the Activity of Costimulatory Molecules and T Cells., PMID:36094100
Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G., PMID:36114130
Phylogenetic and Genomic Characterization of Whole Genome Sequences of Ocular Herpes Simplex Virus Type 1 Isolates Identifies Possible Virulence Determinants in Humans., PMID:37450309
Herpes simplex virus type 1 modifies the protein composition of extracellular vesicles to promote neurite outgrowth and neuroinfection., PMID:38275838
Association between human herpes simplex virus and severe headache or migraine among aged 20-49 years: a cross-sectional study., PMID:39440252
Assessment of IL28 (rs12980275) and (rs8099917) Frequency in Recurrent Ocular Herpes Simplex Virus (HSV) Infection., PMID:40141734
CTLA4 Single-Nucleotide Polymorphisms Influence the Risk of HSV and VZV Infection in Kidney Transplant Recipients: A Prospective Cohort Study., PMID:40469083
Order: order@antibodysystem.com
Mail: support@antibodysystem.com
For research use only. Not for human or drug use.
Find out more about placing an order here
